Search Results1-10 of  10

  • Taku Keisei ID: 9000380492742

    Articles in CiNii:1

    • Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer : a phase Ⅱ trial and biomarker study (WJOG7212G) (2018)
  • Taku Keisei ID: 9000401420841

    Articles in CiNii:1

    • A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2) (2019)
  • Taku Keisei ID: 9000404949230

    Articles in CiNii:1

    • Multicenter phase Ⅱ study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naive, HER2-positive advanced gastric cancer (2019)
  • TAKU KEISEI ID: 9000014220824

    Division of Medical Oncology, Shizuoka General Hospital (2012 from CiNii)

    Articles in CiNii:6

    • Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer (2008)
    • Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer : a retrospective review of 65 Japanese patients (2009)
    • Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer : retrospective analysis (2010)
  • TAKU Keisei ID: 9000014181835

    Articles in CiNii:10

    • Molecular-Targeting Therapy against Malignant Tumor (2007)
    • 臨床 大腸癌の化学療法分子標的治療の進歩 (2006)
    • VEGF標的血管阻害剤--PTK/ZK、ベバシズマブ (特集 分子標的薬のSecond Wave) -- (PART1 各薬剤の開発状況) (2006)
  • TAKU Keisei ID: 9000261045232

    Division of Gastrointestinal Oncology, Shizuoka Cancer Center (2013 from CiNii)

    Articles in CiNii:1

    • Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients (2013)
  • TAKU Keisei ID: 9000261045534

    Division of Gastrointestinal Oncology, Shizuoka Cancer Center (2013 from CiNii)

    Articles in CiNii:1

    • Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer (2013)
  • TAKU Keisei ID: 9000399219223

    Department of Medical Oncology, Shizuoka General Hospital (2018 from CiNii)

    Articles in CiNii:1

    • A case of jejunal neuroendocrine carcinoma complicated with dermatomyositis (2018)
  • Taku Keisei ID: 9000316213328

    Shizuoka General Hospital Medical Oncology (2014 from CiNii)

    Articles in CiNii:1

    • Prognostic Factors in Patients with Unresectable Pancreatic Cancer Treated with Gemcitabine: A Retrospective Analysis (2014)
  • Taku Keisei ID: 9000379605902

    Division of Medical Oncology, Shizuoka General Hospital (2017 from CiNii)

    Articles in CiNii:1

    • Nutrition Care in Internal Medicine (2017)
Page Top